Australian woman wins legal battle against US biotech company’s BRCA genes patent

| | October 8, 2015
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. 

Queensland cancer survivor Yvonne D’Arcy has won a historic High Court victory against the patenting of human genes.

D’Arcy, who has twice survived cancer, brought a landmark legal challenge against US company Myriad Genetics after it was granted a patent over the BRCA 1 and BRCA 2 genes.

Mutations in the genes dramatically increase a woman’s chance of developing breast and ovarian cancer.

The High Court ruled unanimously in Ms D’Arcy’s favour, finding that an isolated nucleic acid was not a “patentable invention”.

The 69-year-old said she was “thrilled” with the result.

“It’s been such a long hard fight and it means so much to so many people,” she said.

“I am so proud to have been part of this case.”

D’Arcy had argued the genes were naturally occurring in the human body and so were “discovered” rather than “invented”.

However, Myriad Genetics had argued that the patent applied to a product — an isolated nucleic acid — that was chemically, structurally and functionally different to naturally occurring DNA.

The High Court’s decision overturns a 2013 ruling by Federal Court judge John Nicholas that found that isolated gene sequences were the product of human intervention and therefore patentable. That decision had been upheld by the full Federal Court.

Consumers Health Forum’s Mark Metherell said the High Court’s finding that a human gene could not be patented was a “victory for consumers, researchers, and for common sense”.

Read full, original post: Yvonne D’Arcy wins High Court battle over breast cancer gene patent

Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
a a b b a f ac a

Video: Death by COVID: The projected grim toll in historical context

The latest statistics, as of July 10, show COVID-19-related deaths in U.S. are just under 1,000 per day nationally, which is ...
mag insects image superjumbo v

Disaster interrupted: Which farming system better preserves insect populations: Organic or conventional?

A three-year run of fragmentary Armageddon-like studies had primed the journalism pumps and settled the media framing about the future ...
dead bee desolate city

Are we facing an ‘Insect Apocalypse’ caused by ‘intensive, industrial’ farming and agricultural chemicals? The media say yes; Science says ‘no’

The media call it the “Insect Apocalypse”. In the past three years, the phrase has become an accepted truth of ...
types of oak trees

Infographic: Power of evolution? How oak trees came to dominate North American forests

Over the course of some 56 million years, oaks, which all belong to the genus Quercus, evolved from a single undifferentiated ...
biotechnology worker x

Can GMOs rescue threatened plants and crops?

Some scientists and ecologists argue that humans are in the midst of an "extinction crisis" — the sixth wave of ...
food globe x

Are GMOs necessary to feed the world?

Experts estimate that agricultural production needs to roughly double in the coming decades. How can that be achieved? ...
eating gmo corn on the cob x

Are GMOs safe?

In 2015, 15 scientists and activists issued a statement, "No Scientific consensus on GMO safety," in the journal Environmental Sciences ...
Screen Shot at PM

Charles Benbrook: Agricultural economist and consultant for the organic industry and anti-biotechnology advocacy groups

Independent scientists rip Benbrook's co-authored commentary in New England Journal calling for reassessment of dangers of all GMO crops and herbicides ...
Screen Shot at PM

ETC Group: ‘Extreme’ biotechnology critic campaigns against synthetic biology and other forms of ‘extreme genetic engineering’

The ETC Group is an international environmental non-governmental organization (NGO) based in Canada whose stated purpose is to monitor "the impact of emerging technologies and ...
Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend